No abstract available
Author Archives: JAIDS
No abstract available
Objective: To examine the uptake of services and behaviors in the prevention of mother-to-child HIV transmission (PMTCT) cascade in Zimbabwe and to determine factors associated with MTCT and maternal antiretroviral therapy (ART) or antiretroviral (ARV) prophylaxis.
Introduction: In Cambodia, the Linked Response (LR) approach for strengthening linkages between HIV and reproductive health services, especially for the prevention of mother-to-child transmission of HIV (PMTCT), was scaled up in 2009.
Background: Approaches to antiretroviral therapy (ART) in HIV-infected pregnant women have changed considerably in recent years, but there are few comparative data on the implementation of different models of service delivery.
Background: Universal access to highly active antiretroviral therapy (HAART) is still elusive in most developing nations.
Background: The first methadone maintenance treatment clinic in Tanzania was launched in February 2011 to address an emerging HIV epidemic among people who inject drugs.
Abstract: With dyadic data from a US Internet sample of 275 HIV-negative and 58 discordant male couples, we assessed HIV-negative partnered men’s attitudes toward using an in-home rapid HIV test (HT) to screen potential new sex partners and associated factors by multivariate multilevel modeling.
Background: A decade after the rollout of antiretroviral therapy (ART) in sub-Saharan Africa, the effects of this structural change on social aspects of HIV, such as rates of HIV disclosure to partners, remain largely unmeasured.
Abstract: HIV testing efforts increased in recent years to reduce the percentage of persons with HIV unaware of their infection and to detect HIV early.
Background: Combination antiretroviral therapy (ART) for HIV-1–infected individuals prevents sexual transmission if viral load is suppressed.
Background: Increased long-term prescription of opioids and/or benzodiazepines necessitates evaluating risks associated with their receipt.
Background: Engagement in HIV care offers clear individual and societal benefits, but little evidence exists on the care experiences of key populations.
Background: Few randomized clinical trials have investigated antiretroviral regimens in very advanced HIV-1–infected patients.